Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study C Font, A Carmona-Bayonas, C Beato, Ò Reig, A Sáez, ... European Respiratory Journal 49 (1), 2017 | 64 | 2017 |
Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index A Carmona-Bayonas, P Jiménez-Fonseca, C Font, F Fenoy, R Otero, ... British journal of cancer 116 (8), 994-1001, 2017 | 46 | 2017 |
On the necessity of new decision-making methods for cancer-associated, symptomatic, pulmonary embolism A Carmona-Bayonas, C Font, P Jiménez-Fonseca, F Fenoy, R Otero, ... Thrombosis Research 143, 76-85, 2016 | 18 | 2016 |
Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer P Jiménez-Fonseca, MP Solis, M Garrido, L Faez, D Rodríguez, AL Ruiz, ... Clinical and Translational Oncology 17, 384-392, 2015 | 18 | 2015 |
Asociación para la Investigación de la Enfermedad Tromboembólica de la región de Murcia. Clinical features and short-term outcomes of cancer patients with suspected and … C Font, A Carmona-Bayonas, C Beato, Ò Reig, A Sáez, ... Eur Respir J 49 (1), 1600282, 2017 | 14 | 2017 |
Prognostic value of computed tomography pulmonary angiography indices in patients with cancer-related pulmonary embolism: data from a multicenter cohort study JM Plasencia-Martínez, A Carmona-Bayonas, D Calvo-Temprano, ... European journal of radiology 87, 66-75, 2017 | 13 | 2017 |
The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolism P Jiménez-Fonseca, A Carmona-Bayonas, C Font, J Plasencia-Martínez, ... Clinical and Translational Oncology 20, 230-242, 2018 | 5 | 2018 |
C0271: incidental versus symptomatic pulmonary embolism (PE) in cancer patients: clinical features and short term outcomes of 562 consecutive patients from the epiphany study A Carmona-Bayonas, C Font, PJ Fonseca, C Beato, L Faez, MA Vicente, ... Thrombosis Research, S3, 2014 | 2 | 2014 |
Biweekly gemcitabine and capecitabine in heavily pretreated patients with metastatic colorectal cancer (mCRC). MDP Solis Hernandez, P Jiménez, L Faez Garcia, C Alvarez Fernandez, ... Journal of Clinical Oncology 31 (15_suppl), e14617-e14617, 2013 | 2 | 2013 |
CP-075 Prognostic factors in patients with recurrent epithelial ovarian cancer AR Palomo, FJA Manceñido, IZ García, LS Lorenzo, PP Villanueva, ... European Journal of Hospital Pharmacy 24 (Suppl 1), A33-A33, 2017 | 1 | 2017 |
Outpatient management of cancer-related pulmonary embolism: a propensity score-matched analysis of 803 patients from the EPIPHANY study A Carmona-Bayonas, M Biosca, CF Puig, L Faez, MDPS Hernández, ... Annals of Oncology 25, iv519, 2014 | 1 | 2014 |
mTOR mutations are not associated with shorter PFS and OS in patients treated with mTOR inhibitors CS Rodriguez, JAA Arija, RM Barrera, J Puente, O Reig, L Faez, ... Annals of Oncology 30, v395-v396, 2019 | | 2019 |
Prognostic role of PD-L1 expression in patients with advanced renal cell carcinoma (RCC) treated with sunitinib. C Iglesias, RI Cereceda García, L Rodríguez Arias, FJ Alvarez Manceñido, ... Journal of Clinical Oncology 37 (7_suppl), 603-603, 2019 | | 2019 |
Tobacco as a possible prognostic factor in advanced renal cell carcinoma. MP Solis-Hernandez, C Iglesias, A Revuelta, C Gonzalez Mendez, ... Journal of Clinical Oncology 37 (7_suppl), 665-665, 2019 | | 2019 |
Analysis of bone events in patients with aromatase inhibitors (AI) SF Arrojo, E Garcia-Carús, C Gómez, P Rodriguez, D Rivas, L Faez, ... Annals of Oncology 29, viii611, 2018 | | 2018 |
Experience with the implant of vascular access devices by medical oncologist in a non-surgical scenery. A Revuelta, D Rodriguez, S Fernandez, C Iglesias, D Gomez, J Sanchez, ... Journal of Clinical Oncology 36 (15_suppl), e22202-e22202, 2018 | | 2018 |
230P Experience with the implant of vascular access devices by medical oncologists in a non-surgical setting A Revuelta, DR Rubí, L Fáez, MDP Solís, SF Arrojo, CI Gómez, D Gómez, ... Journal of Thoracic Oncology 13 (4), S137-S138, 2018 | | 2018 |
Experience with the implant of vascular access devices by medical oncologist in a non-surgical scenery A Revuelta, DR Rubí, MLS Lorenzo, LR Echeverria, W Li, ... Annals of Oncology 28, v561, 2017 | | 2017 |
Efficacy of raltitrexed in refractory metastatic colorectal cancer. A retrospective analysis of 84 patients in HUCA (University Hospital Central of Asturias) A Revuelta, M Solis, S Fernandez-Arrojo, L Faez, C Iglesias, J del Rio, ... Annals of Oncology 28, iii118, 2017 | | 2017 |
TERT as a prognostic factor for gliomas progression-free survival (PFS) MPS Hernandez, L Faez, D Cantero, AH Lain, PS Gomez, Y Ruano, ... Annals of Oncology 27, vi109, 2016 | | 2016 |